Total Pageviews

Thursday, April 26, 2012

Ph.D. Viva-Voce for Mr. B. Ramesh - Many Wishes



We are happy to announce that the Ph.D. Viva-Voce examination for Mr. B. Ramesh, Head, Department of Biotechnology, Sri Sankara Arts & Science College, Kancheepuram is conducted on 27th April, 2012 (10 am) at Chemical Science Auditorium, University of Madras, Guindy Campus, Chennai-25. 


Title of his thesis: Isolation and characterization of Biosurfactant from soil microflora: Evaluation of the efficacy in irrigation water conservation.  


The Staff and Students of Department of Biotechnology whole heartily wishes you for getting this high degree.




   

Saturday, March 17, 2012

Free Short-term Training Programme on Methods in Biotech/ Molecular Biology / Bioinformatics – Chennai

Department of Biotechnology, Ministry of Science and Technology, sponsored

Short-term Training Programme on

Methods in Biotechnology, Molecular Biology and Bioinformatics

2–26 April 2012

at

Department of Plant Biology and Biotechnology
Loyola College (Autonomous), Chennai 600 034, Tamil Nadu

Scope of the Short-term Training Programme

The proposed training programme (18 days) will provide the participants to gain a better understanding of principles, methods and application of biotechnological tools. The participants will be provided hands on training in production of microbial enzymes, methods in plant tissue culture, molecular tools and Agrobacterium mediated transformation in plants. The participants will also gain experience in the use of various bioinformatics tools. This training features interactive talks and activities that will both inspire and help participants towards better research in biotechnology.

Eligibility and selection The training programme is designed for Research Scholars, Young Scientist and Faculty of Life Sciences and Biotechnology. Those interested may apply in the prescribed format along with a brief resume, duly forwarded by the Head of the Department/Institute. Only 15 applicants will be selected for training through screening of application by the course faculty.

Registration fee

There is no registration fee and the training is given free of charges. Outstation participants have to make their own arrangements for accommodation. No TA/DA will be provided to participants.

Application forms will be received till 20 March 2012.

For further details, please contact, Dr J. Joel Gnanadoss, Course Director, Assistant Professor, Department of Plant Biology and Biotechnology, Loyola College (Autonomous), Chennai 600 034, e-mail: joelgna@gmail.com, Phone: 98409 85870.

Monday, February 20, 2012

Project Oriented Biological Education (POBE)

ELIGIBILITY: As part of its Science Outreach Programme, in 2006 the Centre initiated a new program in biology for undergraduate students (only the students who are studying in first year of three years B.Sc program) (preferably having Biology as one of the subjects). from other institutions. Selected students are exposed to the concepts and methodologies driving integrative research in biology today, through a combination of lectures, laboratory projects and research. The programme will be conducted during the summer vacation for a period of 6 to 8 weeks. The total number of Fellowships offered will be up to 10. Scholarship of Rs. 6000/- per month will be provided. Students selected are expected to work at the Centre for three consecutive periods. After the successful completion of the programme at the end of 3 years, the students will a receive a diploma in Biology from the Centre. Where possible, students will be allowed to work in the Centre during mid-semester vacations as well. Specialization in a more focused area or research will be possible during the second and third years. Those who complete the POBE programme with outstanding performance will be eligible for admission to the MS/PhD programme of the Centre subject to satisfactory performance in the interview. Only selected candidates will be intimated by last week of March and the list will also be available on the Centre web site. Further enquiries or correspondence will be not be entertained. The announcement will appear in the media and on our website around January each year. Students who are interested to apply can download the application form click here or obtain it by writing to: The Assistant Coordinator Fellowships and Extension Programmes JNCASR Jakkur Bangalore 560 064. Note : Please ensure that your completed application form is accompanied by two confidential reports from the Referees (in sealed envelopes) and also attested copies of statement of marks.

For Application : http://www.jncasr.ac.in/fe/POBEapplicationform2012final.pdf

Thursday, January 12, 2012

World’s first primate chimeric offspring produced: Research demonstrates not all embryonic stem cells are equal

ScienceDaily (Jan. 5, 2012) — Newly published research by scientists at Oregon Health & Science University provides significant new information about how early embryonic stem cells develop and take part in formation of the primate species. The research, which took place at OHSU's Oregon National Primate Research Center, has also resulted in the first successful birth of chimeric monkeys -- monkeys developed from stem cells taken from two separate embryos.
The research is being published this week in the online edition of the journal Cell and will be published in a future printed copy of the journal.The research was conducted to gain a better understanding of the differences between natural stem cells residing in early embryos and their cultured counterparts called embryonic stem cells. This study also determined that stem cell functions and abilities are different between primates and rodents.Here's more information about the early primate stem cells that were studied: The first cell type was totipotent cells -- cells from the early embryo that have the ability to divide and produce all of the differentiated cells in the placenta and the body of organism. These were compared with pluripotent cells -- cells derived from the later stage embryo that have only the ability to become the body but not placenta.In mice, either totipotent or pluripotent cells from two different animals can be combined to transform into an embryo that later becomes a chimeric animal. However, the current research demonstrated that for reasons yet unknown, chimeric animals can only develop from totipotent cells in a higher animal model: the rhesus macaque. OHSU showed this to be the case by successfully producing the world's first primate chimeric offspring, three baby rhesus macaques named Roku, Hex and Chimero."This is an important development -- not because anyone would develop human chimeras -- but because it points out a key distinction between species and between different kind of stem cells that will impact our understanding of stem cells and their future potential in regenerative medicine," explained Shoukhrat Mitalipov, Ph.D., an associate scientist in the Division of Reproductive and Developmental Sciences at ONPRC."Stem cell therapies hold great promise for replacing damaged nerve cells in those who have been paralyzed due to a spinal cord injury or for example, in replacing dopamine-producing cells in Parkinson's patients who lose these brain cells resulting in disease. As we move stem cell therapies from the lab to clinics and from the mouse to humans, we need to understand what these cells do and what they can't do and also how cell function can differ in species."
Journal Reference:Masahito Tachibana, Michelle Sparman, Cathy Ramsey, Hong Ma, Hyo-Sang Lee, Maria Cecilia T. Penedo, Shoukhrat Mitalipov. Generation of Chimeric Rhesus Monkeys. Cell, 2012; DOI: 10.1016/j.cell.2011.12.007

Friday, December 16, 2011

Why Does the Same Mutation Kill One Person but Not Another?

ScienceDaily (Dec. 7, 2011) — The vast majority of genetic disorders (schizophrenia or breast cancer, for example) have different effects in different people. Moreover, an individual carrying certain mutations can develop a disease, whereas another one with the same mutations may not. This holds true even when comparing two identical twins who have identical genomes. But why does the same mutation have different effects in different individuals?
The figure shows how the same mutation can differently affect each individual from C. elegans. The dice represent the stochastic component in the gene expression. (Credit: Image courtesy of Centre for Genomic Regulation)
Since the early twentieth century researchers have studied the role that genetic variability (mutations) and the environment (consumption habits, lifestyle, etc.) have in the development of diseases. "However, genetic and environmental differences are not enough" said Alejandro Burga, one of the authors of the article. "In the last decade we have learned by studying very simple organisms such as bacteria that gene expression -- the extent to which a gene is turned on or off -- varies greatly among individuals, even in the absence of genetic and environmental variation. Two cells are not completely identical and sometimes these differences have their origin in random or stochastic processes. The results of our study show that this type of variation can be an important influence the phenotype of animals, and that its measurement can help to reliably predict the chance of developing an abnormal phenotype such as a disease ."
The researchers conducted their study using the roundworm Caenorhabditis elegans as a model. Due to its simplicity, this microscopic worm is one of the most widely studied organisms in biology, and was the first animal to have its genome sequenced. Recently three different Nobel Prizes have been awarded for research using C. elegans.
Since the genetic composition and the environment are insufficient to determine whether or not a mutation will affect an individual, they developed a methodology to measure small differences in gene expression in vivo. "The challenge was not only to develop a method to quantify these small differences among individuals, but also to predict which genes are relevant for a particular mutation," adds Ben Lehner, coordinator of the study and ICREA Research Professor in the European Molecular Biology Laboratory-Centre for Genomic Regulation Systems Biology Research Unit. "In both round worms and humans, genes cooperate and help each other to perform functions within the cell. A few genes are very "generous" and help hundreds of others to perform many different processes, whereas others only help a few other genes to perform more specific functions. The key to predict what will happen in each individual is to measure variation in the expression of both types of gene."
The work suggests that, even if we completely understand all of the genes important for a particular human disease, we may never be able to predict what will happen to each person from their genome sequence alone. Rather, to develop personalised and predictive medicine it will also be necessary to consider the varying extent to which genes are turned on or off in each person.
The study was funded by the European Research Council, the Institució Catalana de recerca i Estudis Avanzats (ICREA) and the Ministry of Science and Innovation (MICINN).

Thursday, December 15, 2011

Happy holidays and advance new year wishes

Dear Staff and Students,
Semester holidays are announced from 21/12/11 to 03/01/13. Enjoy your free days and rejuvenate yourself, because we will be having lot of activities in coming months. 17/12/11 will be a working day.

Regards.
Ramesh.B

Lessons Learned from Yeast About Human Leukemia: The Power of Basic Model Organisms in Human Health

ScienceDaily (Dec. 5, 2011) — The trifecta of biological proof is to take a discovery made in a simple model organism like baker's yeast and track down its analogs or homologs in "higher" creatures right up the complexity scale to people, in this case, from yeast to fruit flies to humans. In a pair of related studies, scientists at the Stowers Institute for Medical Research have hit such a trifecta, closing a circle of inquiry that they opened over a decade ago.


Stowers investigator, Ali Shilatifard, Ph.D., and his team finally confirmed that the molecular mechanics of a key regulatory complex implicated in human leukemia, which Shilatifard had first identified in yeast, are the same on each rung of the evolutionary ladder, all the way from yeast to fruit flies to humans. In addition, the Stowers team, working closely with collaborators at the University of Michigan, revealed the common molecular shape at the center of the complex, which regulates gene expression through the methylation of histone H3, one of several DNA packaging proteins.
These findings are important, says Shilatifard, for understanding a fundamental developmental process -- histone methylation. Understanding this protein modification, which protects, packages, and controls the output of expression from DNA, is essential for finding new ways to treat leukemia arising as a result of chromosomal translocations.
About 30 years ago, Janet Rowley, a physician and geneticist, was the first to propose that translocation, the swapping of chromosomal sections into abnormal locations during replication, was a cause of aggressive leukemia. Considered heresy at the time, Rowley's theory was briskly dismissed, but gained adherents as evidence piled up that the translocation of one gene in particular was a marker for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). This most commonly translocated gene became known as MLL or the "mixed-lineage leukemia" gene, and it is widely used today for diagnostics and determining therapy in patients.
Determined to explain just how the misplaced MLL causes leukemia, Shilatifard purified one of the first known interaction partners of human MLL about 16 years ago. Surprisingly, the protein functioned in transcription elongation, a key step in the process that leads to gene expression. Unable to make further progress on MLL in mouse models, he turned to a possible MLL homolog, a gene called Set1, in the humble baker's yeast.
"About 12 years ago, we decided to use yeast, Saccharomyces cerevisiae, as a model system to learn about human leukemia," Shilatifard recalls. "Everyone thought we were out of our minds." Undaunted, the Shilatifard lab extracted Set1 protein from 300 liters of S. cerevisiae culture and found that Set1 belongs to a complex they dubbed COMPASS (Complex of Proteins Associated with Set1). In a major find, they had identified the first H3K4 (histone 3, lysine 4) methylase complex, an enzyme that modifies histones. Histones are protein spools around which long DNA helices are wound inside the cell nucleus. Methylation or demethylation (addition or removal of individual methyl groups) tightens or loosens histone spools, turning genes off or on.
More than a decade later, a study led by postdoctoral fellow Man Mohan, Ph.D., which was featured on the cover of the Nov. 1, 2011, issue of Molecular and Cellular Biology, firmly connects the yeast complex, known as Set1/COMPASS, to its fruit fly homologs, three COMPASS-like complexes built around the Drosophila melanogaster gene, Trithorax (Trx).
The second study, published in the online Early Edition of the Proceedings of the National Academy of Science the week of Dec. 5, 2011, features the work of postdoctoral fellow Yoh-hei Takahasi, Ph.D., who painstakingly reconstituted the Set1/COMPASS from its component molecules both in yeast and human cells.
Working with Gerwin Westfield in the lab of structural biologist Georgios Skiniotis at the University of Michigan, they used state-of-the-art electron microscopy techniques to map out the Y-shaped molecular structure at the heart of the complex. "It was a very challenging project, but I am so glad to see Ali's many years of effort come to fruition and my lab being part of this breakthrough," says Skiniotis.
The mechanisms of histone methylation such as the Set1/COMPASS complex are conserved by evolutionary selection across a wide range of eukaryote organisms, which is why Shilatifard was able to move from the Set1/COMPASS in yeast to three COMPASS-like complexes involving trithorax in Drosophila, to six COMPASS-like complexes in MLL in humans. These factors are now known as the COMPASS family.
"Given the conservation of COMPASS family from yeast to human, having the 3D structure of the core complex not only reveals the fundamental architectural blueprint, but provides molecular insights into the function of the H3K4 methylase complexes," says Shilatifard. "And guess what?" says Shilatifard. "Comparing the overall architectures we cannot tell the difference between the yeast enyme and the human enzyme. They look almost identical!"
It's been a long but satisfying scientific journey to bring the Set1/COMPASS story together, says Shilatifard. "So the lesson learned is that yeast is an excellent model for studying the molecular basis of human leukemia."
Researchers who also contributed to the study published in PNAS include Austin Oleskie at the Life Sciences Institute at the University of Michigan in Ann Arbor and Raymond Trievel in the Department of Biological Chemistry at the University of Michigan Medical School in Ann Arbor. Researchers who also contributed to the study published in MCB include Hans Martin Herz, Edwin R. Smith, Ying Zhang, Michael P. Washburn and Laurence Florens at the Stowers Institute for Medical Research as well as Jessica Jackson and Joel C. Eissenberg in the Edward A. Doisy Department of Biochemistry and Molecular Biology at the Saint Louis University School of Medicine.

Workshop for Teaching Faculties of Life Sciences on ‘Quantification of Biomolecules’


Hearty congratulations for Dr.A.Koodalingam and Mrs.M.Pratheeba for attending Workshop  for Teaching Faculties of Life Sciences on ‘Quantification of Biomolecules’ Organized by Eppendorf India Limited (8.12.2011).


Wednesday, December 14, 2011

A 'Wild Card' in Your Genes

ScienceDaily (Dec. 7, 2011) — The human genome and the endowments of genes in other animals and plants are like a deck of poker cards containing a "wild card" that in a genetic sense introduces an element of variety and surprise that has a key role in life. That's what scientists are describing in a review of more than 100 studies on the topic that appears in ACS Chemical Biology.

Rahul Kohli and colleagues focus on cytosine, one of the four chemical "bases" that comprise the alphabet that the genetic material DNA uses to spell out everything from hair and eye color to risk of certain diseases. But far from just storing information, cytosine has acquired a number of other functions that give it a claim to being the genome's wild card. "In poker, the rules of the game can occasionally change," they note in the article. "Adding a 'wild card' to the mix introduces a new degree of variety and presents opportunities for a skilled player to steal the pot. Given that evolution is governed by the same principles of risk and reward that are common to a poker game, it is perhaps not surprising that a genomic 'wild card' has an integral role in biology."

They discuss the many faces of cytosine that make it such a game-changer and the biological processes that help to change its identity. Removing something called an amine group from cytosine, for instance, allows the immune system to recognize and destroy foreign invaders such as viruses. Adding so-called "methyl groups" on cytosines acts as on/off switches for genes. The authors say that these many faces of cytosine allow it to play various roles and give it true "wild card" status.

Tuesday, December 13, 2011

Educationcal Scholarship Sponsored by MHRD for March 2011


Last date extended up to 30th December. I request all the eligible studetns to apply.
Application can be downloaded from http://tndce.in/NotificationPDF/National%20Merit%20Scholarship.pdf